Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doruk Erkan

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|June 20, 2014
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic reviewSavino Sciascia, Giovanni Sanna, Munther A Khamashta, et al.
Autoimmunity Reviews|January 27, 2022
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry"Brenda López-Benjume, Ignasi Rodríguez-Pintó, Mary Carmen Amigo, et al.
Arthritis Care & Research|July 18, 2013
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literatureLaura Andreoli, Cecilia B Chighizola, Alessandra Banzato, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 2, 2012
Cyclophosphamide responsive interstitial lung disease in "overlap syndrome": a clinical pathology conference held by the division of rheumatology at the hospital for special surgeryElizabeth Schulman, Kun Chen, Gregory Saboeiro, et al.
Autoimmunity Reviews|June 20, 2013
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximabHoracio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
The Journal of Rheumatology|July 3, 2023
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee ReportMedha Barbhaiya, Maxime Taghavi, Stephane Zuily, et al.
Arthritis and Rheumatism|July 27, 2006
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patientsSilvia Bucciarelli, Gerard Espinosa, Ricard Cervera, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 18, 2009
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special SurgeryJessica K Gordon, Cynthia Magro, Theresa Lu, et al.
Autoimmunity Reviews|August 9, 2021
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysisInès Bernardoff, Alexandre Picq, Pierre Loiseau, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|June 20, 2014
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic reviewSavino Sciascia, Giovanni Sanna, Munther A Khamashta, et al.
Autoimmunity Reviews|January 27, 2022
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry"Brenda López-Benjume, Ignasi Rodríguez-Pintó, Mary Carmen Amigo, et al.
Arthritis Care & Research|July 18, 2013
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literatureLaura Andreoli, Cecilia B Chighizola, Alessandra Banzato, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 2, 2012
Cyclophosphamide responsive interstitial lung disease in "overlap syndrome": a clinical pathology conference held by the division of rheumatology at the hospital for special surgeryElizabeth Schulman, Kun Chen, Gregory Saboeiro, et al.
Autoimmunity Reviews|June 20, 2013
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximabHoracio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
The Journal of Rheumatology|July 3, 2023
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee ReportMedha Barbhaiya, Maxime Taghavi, Stephane Zuily, et al.
Arthritis and Rheumatism|July 27, 2006
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patientsSilvia Bucciarelli, Gerard Espinosa, Ricard Cervera, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 18, 2009
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special SurgeryJessica K Gordon, Cynthia Magro, Theresa Lu, et al.
Autoimmunity Reviews|August 9, 2021
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysisInès Bernardoff, Alexandre Picq, Pierre Loiseau, et al.
Pageof 20